Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 559 | 238 | 0 | 0 | 0 |
| Cost of Goods | 32 | 14 | N/A | N/A | N/A |
| Gross Profit | 527 | 224 | N/A | N/A | N/A |
| Operating Expenses | 26,189 | 23,901 | 18,803 | 11,829 | 12,531 |
| Operating Income | -25,630 | -23,663 | -17,257 | -11,829 | -12,531 |
| Interest Expense | 4,725 | 4,135 | 985 | 967 | 951 |
| Other Income | 1,741 | 1,732 | 833 | 874 | 516 |
| Pre-tax Income | -28,614 | -26,066 | -17,409 | -11,922 | -12,966 |
| Net Income Continuous | -28,614 | -26,066 | -17,409 | -11,922 | -12,966 |
| Net Income | $-28,614 | $-26,066 | $-17,409 | $-11,922 | $-12,966 |
| EPS Basic Total Ops | -0.21 | -0.20 | -0.12 | -0.12 | -0.20 |
| EPS Basic Continuous Ops | -0.21 | -0.20 | -0.12 | -0.12 | -0.20 |
| EPS Diluted Total Ops | -0.21 | -0.20 | -0.12 | -0.12 | -0.20 |
| EPS Diluted Continuous Ops | -0.21 | -0.20 | -0.12 | -0.12 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.20 | -0.16 | -0.12 | -0.20 |
| EBITDA(a) | $-25,573 | $-23,607 | $-18,769 | $-11,804 | $-12,503 |